Whether you are attending in-person or virtually, the conference app will help you navigate the meeting and connect with your colleagues from around the globe. Read more
Before you pack your bags, make sure you know everything you will need to get to the 2023 World Conference on Lung Cancer without delay. Read more
As you plan your WCLC 2023 itinerary, don’t miss an important session on your list because you don’t have a ticket. Review the ticketed events schedule and be sure you have any tickets you will need. Read more
Long-term data presented by Dr. Charles Rudin during WCLC 2022 showed significant OS benefit for patients with extensive stage SCLC on pembrolizumab combination versus placebo. Read more
During WCLC 22, Dr. Renelle Myers demonstrated the importance of considering long-term cumulative exposure to air pollutants when assessing individual lung cancer risk. Read more
Dr. Solange Peters showed 24-month overall survival rates were higher with tremelimumab, durvalumab, and chemotherapy versus chemotherapy alone across all subgroups, including those with KRAS, STK11, and KEAP1 mutations. Read more
In a Q&A with ILCN, Dr. Karen Kelly looks back at the moments that made lasting impressions and the presentations with the power to change the practice of thoracic oncology. Read more
Research presented during WCLC 2022 shows patient-centered summaries may help potential participants to better understand the benefits and risks of clinical trials. Read more
Experts evaluate available evidence comparing various strategies, including prophylactic cranial irradiation vs. surveillance, stereotactic radiosurgery vs. whole-brain radiotherapy, and more. Read more
Experts reviewed data that show smoking can reduce innate immunity and suppress the efficacy of anti-cancer agents, leading to poorer outcomes for patients who continue to smoke after their cancer diagnosis. Read more